Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Ulrich Keilholz, Alexander M.M. Eggermont, Dirk Schadendorf et al.|Journal of Clinical Oncology|2005

Cited by 166